Delivery Order SPE2DB24D1007-SPE2DB24FCAMN
Award Date
9/18/24
Potential Completion Date
9/19/24
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $9,914.10 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Dupixent 300 mg/2 ml pens. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop...
The Defense Logistics Agency (DLA) awarded a $7,448.13 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs globally. The contract has no set-aside...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $60,934.22 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Dupixent 300 mg/2 ml pens. This contract has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $12,507.37 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. This order is for the supply of the specialty pharmaceutical product Dupixent 300 mg/2 ml pen, with an ultimate completion date of March 19, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,219.13 firm-fixed-price contract is for the delivery of Dupixent 300 mg/2 ml pens and has an ultimate completion date of December 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,999.99 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens, with an ultimate completion date of April 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This is a $28,643.92 delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Dupixent 300 mg/2 ml pens. The contract has a firm fixed price and an ultimate completion date of April 15, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pens. The delivery order is valued at $15,372.05 and has a period of performance through September 9, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and covers the delivery of a wide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,869.37 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens, with a performance period that extends through April 17, 2025. The contract is not set aside and represents an individual delivery order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $47,157.90 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of July 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a wide range of...